Author:
Shelley M,Harrison C,Coles B,Wilt T,Mason M
Reference13 articles.
1. Eligibility and response guidelines for phase II clinical trials in androgen -independent prostate cancer: Recommendations from the ProstateSpecific Antigen Working Group;Bubley;Journal of Clinical Oncology,1999
2. Comtempory results of anatomical prostatectomy;Catalona;Ca Cancer Journal for Clinicians,1999
3. Optimal hormone therapy for advanced prostatic carcinoma;Goktas;Seminars in Oncology,1999
4. Phase II study of estramustine and vinblastin, two microtubule inhibitors, in hormone-refractory prostate cancer;Hudes;Journal of Clinical Oncology,1992
5. Paclitaxel plus estramustine in metastatic hormone-refractory prostate cancer;Hudes;Seminars in Oncology,1995